Page last updated: 2024-10-15

n-(deoxyguanosin-8-yl)-1-aminopyrene

Description

N-(deoxyguanosin-8-yl)-1-aminopyrene: major DNA adduct in female rats treated with 1-nitropyrene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135562703
MeSH IDM0131626

Synonyms (10)

Synonym
ndgap
guanosine, 2'-deoxy-8-(1-pyrenylamino)-
85989-43-1
n-(deoxyguanosin-8-yl)-1-aminopyrene
2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-(pyren-1-ylamino)-3h-purin-6-one
2'-seoxy-8-(1-pyrenylamino)guanosine
9-(2-deoxypentofuranosyl)-2-imino-8-[(pyren-1-yl)imino]-3,7,8,9-tetrahydro-2h-purin-6-ol
DTXSID201006568
2'-deoxy-8-(1-pyrenylamino)guanosine
2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-(pyren-1-ylamino)-1h-purin-6-one

Dosage Studied

ExcerptReference
" 1,6-Dinitropyrene dosing did not affect the levels of 8-hydroxy-2'-deoxyguanosine in these two tissues."( Formation of DNA adducts and oxidative DNA damage in rats treated with 1,6-dinitropyrene.
Beland, FA; Culp, SJ; Djurić, Z; Luongo, DA; Potter, DW, 1993
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (8.33)18.7374
1990's6 (50.00)18.2507
2000's5 (41.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]